Rare Cancer Research Data Platform Development

The contract seeks the design and implementation of technical and organizational platforms dedicated to the collection, sharing, and analysis of rare cancer clinical and preclinical datasets. It is issued as a subcontract under the Department of the Army through USAMRAA, with the NAICS code 541715 indicating it falls under research and development in the biological sciences. The goal is to establish a robust infrastructure that enables secure, standardized, and interoperable handling of complex cancer data across research institutions, supporting accelerated discovery and collaboration in oncology research. The platform must integrate advanced data management protocols, ensure compliance with data privacy and security standards, and facilitate analytical capabilities tailored to the unique challenges of rare cancer datasets. The opportunity was posted on June 17, 2026, with a response deadline of November 18, 2026. There is no specified set-aside designation or geographic restriction for performance, and no point of contact details are provided in the solicitation. The work is expected to require expertise in bioinformatics, data governance, cloud-based infrastructure, and clinical research systems, with a focus on interoperability and scalability. The absence of a place of performance assignment suggests the project may involve distributed collaboration across multiple locations or remote delivery. Interested parties must respond by the deadline to be considered for this subcontract under the Department of Defense’s broader mission to advance rare cancer research through data-driven innovation.